Zoghbi Huda Y
SEC CIK 1681643 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Dir | 2,503 | — | $5.78M | 17 | 2021-09-13 | 2026-08-10 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-12 16:14 | 2026-08-10 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | M - OptEx | $376.69 | +800 | 2,503 | +47% | +$301.4K |
| DT | 2026-08-12 16:14 | 2026-08-10 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | S - Sale+OE | $800.00 | -800 | 1,703 | -32% | -$640.0K |
| DM | 2026-02-23 | 2026-02-19 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | S - Sale+OE | $781.33 | -1,638 | 3,242 | -34% | -$1.28M |
| D | 2026-02-23 | 2026-02-19 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | M - OptEx | $376.69 | +1,638 | 3,341 | +96% | +$617.0K |
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | A - Grant | $0.00 | +155 | 1,703 | +10% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | A - Grant | $0.00 | +166 | 1,548 | +12% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | M - OptEx | $391.92 | +1,117 | 2,364 | +90% | +$437.8K |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | S - Sale+OE | $900.00 | -1,117 | 1,247 | -47% | -$1.01M |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | A - Grant | $0.00 | +135 | 1,382 | +11% | $0 |
| D | 2023-10-17 | 2023-10-13 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | S - Sale+OE | $850.00 | -1,000 | 1,247 | -45% | -$850.0K |
| D | 2023-10-17 | 2023-10-13 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | M - OptEx | $391.92 | +1,000 | 2,247 | +80% | +$391.9K |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | A - Grant | $0.00 | +165 | 1,247 | +15% | $0 |
| D | 2022-03-18 | 2022-03-16 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | S - Sale+OE | $675.00 | -2,000 | 1,082 | -65% | -$1.35M |
| D | 2022-03-18 | 2022-03-16 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | M - OptEx | $391.92 | +2,000 | 3,082 | +185% | +$783.8K |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | A - Grant | $0.00 | +191 | 1,082 | +21% | $0 |
| DM | 2021-09-15 | 2021-09-13+ | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | S - Sale+OE | $650.00 | -1,000 | 891 | -53% | -$650.0K |
| DM | 2021-09-15 | 2021-09-13+ | REGN | Regeneron Pharmaceuticals | Zoghbi Huda Y | Dir | M - OptEx | $391.92 | +1,000 | 893 | New | +$391.9K |
Purchase Sale Sale after option exercise All abbreviations